BRANDON RUVALCABA: Open Payments
NPI 1811567720 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$36 in 2 payments from 2 companies in 2025. Trend: 2023 $118 · 2024 $369 · 2025 $36
Food & beverage: $36
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: INGREZZA, Auvelity.
Industry payments across OH — which companies pay providers there.
